MOF-801 as a Nanoporous Water-Based Carrier System for In Situ Encapsulation and Sustained Release of 5-FU for Effective Cancer Therapy

Ag@MUT-16 nanocomposite as a Fenton-like and plasmonic photocatalyst for degradation of Quinoline Yellow under visible light

A new cobalt-based metal-organic framework with the chemical formula of [Co2(DClTPA)2(DABCO)]·(DMF)4 (MUT-16) containing 1,4-diazabicyclo[2.2.2]octane (DABCO) and 2,5-dichloroterephthalic acid (DClTPA) has been designed and prepared through a solvothermal method. MUT-16 (MUT = Materials from University of Tehran) crystallized in a tetragonal system with I41/acd space group, based on single-crystal X-ray analysis. The Ag@MUT-16 nanocomposite was prepared using Ag nanoparticles (NPs) loaded into/onto porous MUT-16via photoreduction route (PR). The MUT-16 and Ag@MUT-16 were characterized using various techniques, such as PXRD, FT-IR, FE-SEM, TEM, EDX, N2 adsorption-desorption isotherms, TGA, DRS, PL, EIS, and Mott-Schottky measurements. The Ag@MUT-16 nanocomposite showed photocatalytic activity of 87.75% in the degradation of Quinoline Yellow (QY) after 30 min under visible light irradiation. The distinctive characteristics of the Ag@MUT-16 nanocomposite, such as the Fenton-like effect of Co2+ ions, surface plasmon resonance (SPR) of Ag NPs, Schottky junction at interfaces between Ag NPs and MUT-16, and reduction of electron-hole recombination through electron trapping by Ag NPs as co-catalyst, all play significant roles in the photocatalytic degradation of Quinoline Yellow (QY).

Current status of controlled onco-therapies based on metal organic frameworks

Despite consecutive efforts devoted to the establishment of innovative therapeutics for cancer control, cancer remains as a primary global public health concern. Achieving controlled release of anti-cancer agents may add great value to the field of oncology that requires the involvement of nanotechnologies. Metal organic frameworks (MOFs) hold great promise in this regard owing to their unique structural properties. MOFs can act as superior candidates for drug delivery given their porous structure and large loading area, and can be prepared into anti-cancer therapeutics by incorporating stimuli-sensitive components into the ligands or nodes of the framework. By combing through chemical and physical features of MOFs favorable for onco-therapeutic applications and current cancer treatment portfolios taking advantages of these characteristics, this review classified MOFs feasible for establishing controlled anti-cancer modalities into 6 categories, outlined the corresponding strategies currently available for each type of MOF, and identified understudied areas and future opportunities towards innovative MOF design for improved or expanded clinical anti-cancer applications.

Harnessing Natural Evaporation for Electricity Generation using MOF-Based Nanochannels

Functionalized nanochannels can convert environmental thermal energy into electrical energy by driving water evaporation. This process involves the interaction between the solid-liquid interface and the natural water evaporation. The evaporation-driven water potential effect is a novel green environmental energy capture technology that has a wide range of applications and does not depend on geographical location or environmental conditions, it can generate power as long as there is water, light, and heat. However, suitable materials and structures are needed to harness this natural process for power generation. MOF materials are an emerging field for water evaporation power generation, but there are still many challenges to overcome. This work uses MOF-801, which has high porosity, charged surface, and hydrophilicity, to enhance the output performance of evaporation-driven power generation. It can produce an open circuit voltage of ≈2.2 V and a short circuit current of ≈1.9 µA. This work has a simple structure, easy preparation, low-cost and readily available materials, and good stability. It can operate stably in natural environments with high practical value.

The antibacterial activity of three zeolitic-imidazolate frameworks and zinc oxide nanoparticles derived from them

Zinc has been widely studied for its antibacterial properties due to its low toxicity, availability, and low cost. This research focused on analysing the antibacterial effects of three types of MOFs (metal-organic frameworks) with zinc as the central metal: ZIF-4, ZIF-7, and ZIF-8. The study found that ZIF-8 had the strongest antibacterial effect, while ZIF-7 had the weakest among them. These findings were consistent with the results of the ICP (inductively coupled plasma) analysis, which measured the amount of zinc released. Additionally, the antibacterial effect of ZIF-8 was found to be higher than that of zinc oxide species obtained from calcination of the compounds. Among the zinc oxide samples, ZnO nanoparticles which derived from ZIF-4 showed the highest antibacterial activity.

Effects of Fluorinated Functionalization of Linker on Quercetin Encapsulation, Release and Hela Cell Cytotoxicity of Cu-Based MOFs as Smart pH-Stimuli Nanocarriers

Controlled delivery of target molecules is required in many medical and chemical applications. For such purposes, metal-organic frameworks (MOFs), which possess desirable features such as high porosity, large surface area, and adjustable functionalities, hold great potential as drug carriers. Herein, Quercetin (QU), as an anticancer drug, was loaded on Cu2 (BDC)2 (DABCO) and Cu2 (F4 BDC)2 )DABCO) MOFs (BDC=1,4-benzenedicarboxylate and DABCO=1,4-diazabicyclo[2.2.2]octane). As these Cu-MOFs have a high surface area, an appropriate pore size, and biocompatible ingredients, they can be utilized to deliver QU. The loading efficiency of QU in these MOFs was 49.5 % and 41.3 %, respectively. The drug-loaded compounds displayed sustained drug release over 15 days, remarkably high drug loading capacities and pH-controlled release behavior. The prepared nanostructures were characterized by different characterization technics including FT-IR, PXRD, ZP, TEM, FE-SEM, UV-vis, and BET. In addition, MTT assays were carried out on the HEK-293 and HeLa cell lines to investigate cytotoxicity. Cellular apoptosis analysis was performed to investigate the cell death mechanisms. Grand Canonical Monte Carlo simulations were conducted to analyze the interactions between MOFs and QU. Moreover, the stability of MOFs was also investigated during and after the drug release process. Ultimately, kinetic models of drug release were evaluated.

Magnetic UiO-66-NH2 Core-Shell Nanohybrid as a Promising Carrier for Quercetin Targeted Delivery toward Human Breast Cancer Cells

In this study, a magnetic core-shell metal-organic framework (MOF) nanocomposite, Fe3O4-COOH@UiO-66-NH2, was synthesized for tumor-targeting drug delivery by incorporating carboxylate groups as functional groups onto ferrite nanoparticle surfaces, followed by fabrication of the UiO-66-NH2 shell using a facile self-assembly approach. The anticancer drug quercetin (QU) was loaded into the magnetic core-shell nanoparticles. The synthesized magnetic nanoparticles were comprehensively evaluated through multiple techniques, including FT-IR, PXRD, FE-SEM, TEM, EDX, BET, UV-vis, ZP, and VSM. Drug release investigations were conducted to investigate the release behavior of QU from the nanocomposite at two different pH values (7.4 and 5.4). The results revealed that QU@Fe3O4-COOH@UiO-66-NH2 exhibited a high loading capacity of 43.1% and pH-dependent release behavior, maintaining sustained release characteristics over a prolonged duration of 11 days. Furthermore, cytotoxicity assays using the human breast cancer cell line MDA-MB-231 and the normal cell line HEK-293 were performed to evaluate the cytotoxic effects of QU, UiO-66-NH2, Fe3O4-COOH, Fe3O4-COOH@UiO-66-NH2, and QU@Fe3O4-COOH@UiO-66-NH2. Treatment with QU@Fe3O4-COOH@UiO-66-NH2 substantially reduced the cell viability in cancerous MDA-MB-231 cells. Cellular uptake and cell death mechanisms were further investigated, demonstrating the internalization of QU@Fe3O4-COOH@UiO-66-NH2 by cancer cells and the induction of cancer cell death through the apoptosis pathway. These findings highlight the considerable potential of Fe3O4-COOH@UiO-66-NH2 as a targeted nanocarrier for the delivery of anticancer drugs.

ZIF-67 grafted-boehmite-PVA composite membranes with enhanced removal efficiency towards Cr(VI) from aqueous solutions

In this work, we developed a thin membrane of boehmite-polyvinyl alcohol composite (BOPOM) (diameter ∼ 5 cm) grafted ZIF-67 combing sol-gel and in-situ growth methods. The fabricated materials were characterized using FT-IR, SEM, XRD, TGA, XPS, and N2 sorption techniques. Results indicate that ZIF-67 nanocrystals were well-grafted into the AlOOH-PVA matrix with reduced crystallite size. Furthermore, the decorated ZIF-67 offered additional porous structures and adsorption sites onto the membrane, enhancing their removal efficiency towards Cr6+ compared to the undecorated and pristine ZIF-67. At pH ∼5.5, the harvested ZIF-67/BOPOM exhibited the highest Cr6+ uptake capacity of ∼56.4 mg g-1. Kinetic studies showed that the chromium adsorption on the prepared materials obeyed the pseudo-second-order model, and the kinetic parameters followed the order ZIFF-67/BOPOM (0.020 mg g-1 min-1) > BOPOM (0.011 mg g-1 min-1) > ZIF-67 (0.006 mg g-1 min-1). Notably, the adsorption mechanism study revealed that adsorbed Cr6+ was reduced to Cr3+, and the reduction yield was boosted owing to grafting ZIF-67 into the BOPOM. In addition, the fabricated ZIF-67/BOPOM can simultaneously remove Cr6+ and methyl orange dye (MO) in the solution due to their synergetic effects on each other. Furthermore, the hybrid membrane ZIF-67/BOPOM showed a chromium removal efficiency of ∼78.2% after four successive adsorption-desorption cycles. This study indicates that grafting nanocrystals ZIF-67 onto the super-platform boehmite-PVA is a promising strategy to harvest an adsorbent with a high adsorption ability, cost-effectiveness, and reduced secondary pollution risks.

Heterostructured Ag@MOF-801/MIL-88A(Fe) Nanocomposite as a Biocompatible Photocatalyst for Degradation of Reactive Black 5 under Visible Light

Heterostructured Ag@MOF-801/MIL-88A(Fe) nanocomposite was synthesized through template effects in metal-organic frameworks (MOFs). MIL-88A(Fe) was fabricated on a MOF-801 template using the internal extended growth method (IEGM) via polyvinylpyrrolidone (PVP) as the structure-director agent to create the MIL-88A(Fe)-on-MOF-801 heterostructure. The MOF-801/MIL-88A(Fe) heterostructure was used as a template for the formation of Ag nanoparticles (NPs) inside it via a double solvents method (DSM) combined with a photoreduction route (PR). To characterize synthesized samples to a high level of detail, PXRD, FT-IR, EDX, N2 adsorption-desorption isotherms, TEM, DRS, PL, EIS, and Mott-Sckottky measurements were used. The resulting Ag@MOF-801/MIL-88A(Fe) nanocomposite demonstrated the highest photocatalytic activity of 91.72% for the degradation of Reactive Black 5, after 30 min under visible light irradiation.

Engineered Catalyst Based on MIL-68(Al) with High Stability for Hydrogenation of Carbon Dioxide and Carbon Monoxide at Low Temperature

Today, the importance of decreasing and converting COx gases from the atmosphere into value-added chemicals by catalytic hydrogenation reactions has become one crucial challenge. In the current work, to facilitate the hydrogenation of COx, several mesoporous alumina catalysts with high efficiency and stability were synthesized using the MIL-68(Al) platform, a nanoporous MOF with a high surface area as a precatalyst, encapsulating nickel or nickel-iron nanoparticles (NPs). After removing the organic linker of MIL-68(Al) by calcination in air, two types of catalysts, promoted and unpromoted, were obtained with various loads of nickel and iron. A set of analyses (PXRD, BET-N2, TEM, FE-SEM, ICP-OES, EDX-map, CO2-TPD, H2-TPR, and H2-TPD) were performed to evaluate the physicochemical properties of catalysts. Based on the analysis results, the promoted catalyst had smaller particles and pores due to the effective and uniform distribution of nickel NPs. Also, H2-TPR and CO2-TPD results in samples containing Fe promoter demonstrated the facilitation of the reduction process and the adsorption and activation of CO2, respectively. The results of CO2 methanation indicated an improved catalytic performance for promoted samples, especially at low temperatures (200-300 °C), compared to unpromoted catalysts. 5Fe·15Ni@Al2O3 MIL-68(Al) catalyst displayed the best performance compared to other catalysts, with a conversion of 92.4% and selectivity of 99.6% at 350 °C and GHSV = 2500 h-1. Moreover, the 5Fe·15Ni@Al2O3 MIL-68(Al) catalyst facilitated the CO2 methanation reaction by reducing the activation energy to 42.5 kJ mol-1 compared with other reported catalysts. Both types of catalysts performed 100% hydrogenation of CO to CH4 with full selectivity at 250 °C and exhibited high stability for at least 100 h at 300 °C. Notably, such high significant catalytic performance is only achieved by the usage of the "MOFs templating strategy" due to the high surface area for the effective distribution of NPs, the strong metal-support interaction, and the formation of nickel aluminate species, preventing the sintering of NPs.

Improved Cytotoxicity and Induced Apoptosis in HeLa Cells by Co-loading Vitamin E Succinate and Curcumin in Nano-MIL-88B-NH2

One of the strategies for improved therapeutic effects in cancer therapy is combination chemotherapy. In this study, a flexible nano-MOF (Fe-MIL-88B-NH2 ) was synthesized in a sonochemical process, then co-loaded with α-tocopheryl succinate (TOS) and curcumin (CCM). The anticancer activity of co-loaded Fe-MIL-88B-NH2 (Fe-MIL-88B-NH2 /TOS@CCM) against the HeLa cells was compared with that of the single-loaded counterpart (Fe-MIL-88B-NH2 @CCM). MTT analysis indicates improved cytotoxicity of Fe-MIL-88B-NH2 /TOS@CCM. The data from the cell apoptosis assay indicated more apoptosis in the case of the co-loaded nano-MOF. This study indicates the positive effect of the presence of TOS on enhancing the anticancer effect of Fe-MIL-88B-NH2 @CCM to prepare a more efficient drug delivery nanosystem.

Metal-organic framework based drug delivery systems as smart carriers for release of poorly soluble drugs hydrochlorothiazide and dapsone

Drug delivery systems (DDSs) that are derived from biocompatible carriers are attractive platforms for sustained release of drugs. In particular, sustained and controlled release of poorly soluble BCS (Biopharmaceutics Classification System) class IV drugs is important and this requires the development of new DDSs. In this work, we exploit two porous metal-organic frameworks (MOFs) MIL-100(Fe) and MIL-53(Fe) as carriers/DDSs for the release of two BCS class IV drugs hydrochlorothiazide (HCT) and dapsone (DAP). The chosen MOFs are known to possess good physicochemical stability and we realized high drug loading capacity that is attributed to the high porosity of the MOFs. The drug-encapsulated MOFs were characterized thoroughly and our results show ∼23.1% loading of HCT in MIL-100(Fe) and ∼27.6% loading of DAP in MIL-Fe(53), respectively. The release study of these drugs was carried out under simulated physiological conditions that shows sustained release of the drug molecules from the MOFs up to 72 h. Cell viability studies through MTT assays show insignificant cytotoxicity signalling biocompatibility of the proposed DDSs. Our investigations suggest MIL-100(Fe) and MIL-53(Fe) are potential DDSs for enhancing the performance of poorly soluble drugs HCT and DAP.

Biocompatible Drug Delivery System Based on a MOF Platform for a Sustained and Controlled Release of the Poorly Soluble Drug Norfloxacin

Norfloxacin (NFX), an important antibacterial fluoroquinolone, is a class IV drug according to the biopharmaceutics classification system (BCS) and has low solubility and permeability issues. Such poor physicochemical properties of drug molecules lead to poor delivery and are of serious concern to the pharmaceutical industry for clinical development. We present here a conceptually new approach to deliver NFX, by loading the drug molecule on the porous platform of a biocompatible metal-organic framework (MOF), MIL-100(Fe). The loading of the drug on the MOF leading to NFX@MIL-100(Fe) was characterized by Fourier transform infrared (FTIR), UV-visible spectroscopy, thermogravimetric analyses (TGA), and nitrogen adsorption studies. Controlled experiments resulted in the high loading of the drug molecule (∼20 wt %) along with the desired sustained release. We could further control the release of norfloxacin by coating drug-loaded MIL-100(Fe) with PEG, PEG{NFX@MIL-100(Fe)}. Both drug delivery systems (DDSs), NFX@MIL-100(Fe) and PEG{NFX@MIL-100(Fe)}, were tested for their biocompatibility through toxicity studies. The DDSs are biocompatible and show insignificant cytotoxicity, as revealed by cell viability studies through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.

Advances in surface-modified nanometal-organic frameworks for drug delivery

Nanometal-organic frameworks (NMOFs) are porous network structures composed of metal ions or metal clusters through self-assembly. NMOFs have been considered as a promising nano-drug delivery system due to their unique properties such as pore and flexible structures, large specific surface areas, surface modifiability, non-toxic and degradable properties. However, NMOFs face a series complex environment during in vivo delivery. Therefore, surface functionalization of NMOFs is vital to ensure that the structure of NMOFs remain stable during delivery, and can overcome physiological barriers to deliver drugs more accurately to specific sites, and achieve controllable release. In this review, the first part summarizes the physiological barriers that NMOFs faced during drug delivery after intravenous injection and oral administration. The second part summarizes the current main ways to load drugs into NMOFs, mainly including pore adsorption, surface attachment, formation of covalent/coordination bonds between drug molecules and NMOFs, and in situ encapsulation. The third part is the main review part of this paper, which summarizes the surface modification methods of NMOFs used in recent years to overcome the physiological barriers and achieve effective drug delivery and disease therapy, which are mainly divided into physical modifications and chemical modifications. Finally, the full text is summarized and prospected, with the hope to provide ideas for the future development of NMOFs as drug delivery.

A review of recent developments of metal-organic frameworks as combined biomedical platforms over the past decade

Metal-organic frameworks (MOFs), also called porous coordination polymers, represent a class of crystalline porous materials made up of organic ligands and metal ions/metal clusters. Herein, an overview of the preparation of different metal-organic frameworks and the recent advances in MOF-based stimuli-responsive drug delivery systems (DDSs) with the drug release mechanisms including pH-, temperature-, ion-, magnetic-, pressure-, adenosine-triphosphate (ATP)-, H₂S-, redox-, responsive, and photoresponsive MOF were rarely introduced. The combination therapy containing of two or more treatments can be enhanced treatment effectiveness through overcoming limitations of monotherapy. Photothermal therapy (PTT) combined with chemotherapy (CT), chemotherapy in combination with PTT or other combinations were explained to overcome drug resistance and side effects in normal cells as well as enhancing the therapeutic response. Integrated platforms containing of photothermal/drug-delivering functions with magnetic resonance imaging (MRI) properties exhibited great advantages in cancer therapy.

An oxygen-generating metal organic framework nanoplatform as a “synergy motor” for extricating dilemma over photodynamic therapy

Photodynamic therapy (PDT) combined with metal organic frameworks (MOFs) addresses current obstacles.

Recent Advances in Metal-Organic-Framework-Based Nanocarriers for Controllable Drug Delivery and Release

Metal-organic frameworks (MOFs) have a good designability, a well-defined pore, stimulus responsiveness, a high surface area, and a controllable morphology. Up to now, various MOFs have been widely used as nanocarriers and have attracted lots of attention in the field of drug delivery and release because of their good biocompatibility and high-drug-loading capacity. Herein, we provide a comprehensive summary of MOF-based nanocarriers for drug delivery and release over the last five years. Meanwhile, some representative examples are highlighted in detail according to four categories, including the University of Oslo MOFs, Fe-MOFs, cyclodextrin MOFs, and other MOFs. Moreover, the opportunities and challenges of MOF-based smart delivery vehicles are discussed. We hope that this review will be helpful for researchers to understand the recent developments and challenges of MOF-based drug-delivery systems.

A 2D Porous Zinc-Organic Framework Platform for Loading of 5-Fluorouracil

A hydrostable 2D Zn-based MOF, {[Zn(5-PIA)(imbm)]·2H2O}n (1) (5-H2PIA = 5-propoxy-isophthalic acid, imbm = 1,4-di(1H-imidazol-1-yl)benzene), was synthesized and structurally characterized. Complex 1 shows good water and thermal stability based on the TGA and PXRD analyses and displays a 2D framework with 1D channels of 4.8 × 13.8 and 10.0 × 8.3 Å2 along the a axis. The 5-fluorouracil (5-FU) payload in activated complex 1 (complex 1a) is 19.3 wt%, and the cumulative release value of 5-FU at 120 h was about 70.04% in PBS (pH 7.4) at 310 K. In vitro MTT assays did not reveal any cytotoxic effect of NIH-3T3 and HEK-293 cells when the concentration of 1 was below 500 μg/mL and 5 μg/mL, respectively. No morphological abnormalities were observed on zebrafish exposed to complex 1.

Metal-Organic Framework with Near-Infrared Luminescence for "Switch-on" Determination of Kaempferol and Quercetin by the Antenna Effect

The establishment of a reliable and sensitive method for the detection of flavonoids, such as kaempferol (Kae) and quercetin (Que), is important and challenging in food chemistry and pharmacology because numerous structural analogues may interfere with the detection. Until now, designing an efficient switch-on fluorescence sensing strategy for Kae and Que was still in the unachievable stage. In this work, a switch-on near-infrared (NIR) luminescence sensing assay for Kae and Que was fabricated based on a metal-organic framework (MOF) called IQBA-Yb for the first time. The fluorescence enhancing mechanism was that analytes served as additional "antenna" of Yb³⁺, leading to the efficient switch-on NIR emission under excitation at 467 nm. Meanwhile, the combination results of experiment and theoretical calculation revealed that there existed hydrogen bonds between Kae, Que, and the MOF skeleton, further promoting the energy transfer between the analyte and Yb³⁺ and facilitating fluorescence enhancement response. The developed probe possessed excellent sensing capability for Kae and Que, accompanied by a wide linear range (0.04-70, 0.06-90 μM), low detection limit (0.01, 0.06 μM), and short response time (20 min, 6 min), which was used to determine the Kae and Que contents in Green Lake and eatable Que samples with satisfactory results.

Smart Multifunctional UiO-66 Metal-Organic Framework Nanoparticles with Outstanding Drug-Loading/Release Potential for the Targeted Delivery of Quercetin

Herein, UiO-66 and its two functional analogs (with -NO₂ and -NH₂ functional groups) were synthesized, and their potential ability as pH stimulus nanocarriers of quercetin (QU), an anticancer agent, was studied. UiO-66 is a low-toxicity, biocompatible metal-organic framework with a large surface area and good stability, which can be prepared through a facile and inexpensive method. Before and after drug loading, various analyses were conducted to characterize the synthesized nanocarriers. Moreover, Monte Carlo simulations were performed to investigate their structures and interactions with quercetin. The most promising drug loading potential and prolonged drug release (over 25 days) were observed in QU@UiO-66-NO₂ with 37% drug loading content, which was the best-tested sample that exhibited a higher release rate under acidic conditions (pH = 5) than that in normal cells (pH = 7.4). This behavior is known as pH-stimulus-controlled ability. The cell treatment with free QU, UiO-66-R, and QU@UiO-66-R (R = -H, -NO₂, and -NH₂) was performed, and an MTT assay was conducted on HEK-293 and MDA-MB-231 cells for the cytotoxicity study. Additionally, the kinetic modeling of drug release was investigated on the basis of the analysis of the drug release profiles.